Expression of the c-myc oncogene and the presence of HPV 18: Possible surrogate markers for cervical cancer?

British Journal of Biomedical Science

Volumn 66, Issue 2, 2009, Pages 74-78

  Rughooputh, Sanjiv ^a,b   Manraj, S ^c   Eddoo, R ^c   Greenwell, P ^d  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b Healthcare and Wellbeing Solutions   (Mauritius)

^c Central Health Laboratory Candos   (Mauritius)

^d UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Genes, myc; Human papillomavirus; Immunohistochemistry; Uterine cervical neoplasms

Indexed keywords

MYC PROTEIN; VIRUS DNA;

ADULT; AGED; ARTICLE; BIOINFORMATICS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

HUMAN PAPILLOMAVIRUS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENES, MYC; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 69249168764     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2009.11730248     Document Type: Article

References (39)

1. Rughooputh S, Kachaliya S, Jetly D, Greenwell P. Cervical cancer and human papillomavirus among slum dwellers in India. Br J Biomed Sci 2007; 64: 28-31. (Pubitemid 46952969)
2. Brake T, Lambert PF. Estrogen contributes to the onset, persistence and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 2005; 102: 2490-2495 (Pubitemid 40279404)
3. Rughooputh S, Eddoo R, Manraj S, Jeebun N, Greenwell P. Detection of human papillomavirus from archival tissues in cervical cancer patients in Mauritius. J Clin Virol 2006; 35: 173-178 (Pubitemid 43053393)
4. Deerasamee S, Srivatanakul P, Sriplung H et al. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand. Asian Pac J Cancer Prev 2007; 8: 547-556
5. Diaz M, Kim JJ, Albero G et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer 2008; 99: 230-238
6. Ordóñez RM, Espinosa AM, Sánchez-González DJ, Armendáriz-Borunda J, Berumen J. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gen Virol 2004; 85: 1433-1444 (Pubitemid 38811424)
7. Cutts FT, Franceschi S, Goldie S et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ 2007; 85: 719-726 (Pubitemid 47416724)
8. Simon P, Poppe W. Should the anti-papillomavirus vaccination after the age of 25 be advised? (in French). J Gynecol Obstet Biol Reprod (Paris) 2008; 37 (8): 748-752
9. Clifford GM, Gallus S, Herrero R et al. IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-998
10. Heilmann V, Kreienberg R. Molecular biology of cervical cancer and its precursors. Curr Womens Health Rep 2002; 2: 27-33.
11. Brenna SMF, Zeferino LC, Pinto GA et al. C-myc protein expression is not an independent prognostic predicator in cervical squamous cell carcinoma. Braz J Med Biol Res 2002; 35: 425-430 (Pubitemid 34467331)
12. Peitsaro P, Hietanen S, Johansson B, Lakkala T, Syrjanen S. Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. Carcinogenesis 2002; 23: 1057-1064 (Pubitemid 34752963)
13. Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O, Rice JM. K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 1990; 50: 6139-6145 (Pubitemid 20323664)
14. Rughooputh S. The role of sexually transmitted organisms in the pathogenesis of cervical cancer. PhD thesis. 2003. University of Westminster, UK.
15. Ting Y, Manos M. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ eds. PCR protocols: a guide to methods and applications. New York: Academic Press, 1990: 356-357
16. Vijayalakshmi N, Selvaluxmi G, Mahji U, Rajkumar T. C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study. Eur J Gynaecol Oncol 2002; 23: 135-138 (Pubitemid 34297117)
17. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-410 (Pubitemid 20364473)
18. Ngan HY, Cheung AN, Liu SS, Cheng DK, Ng TY, Wong LC. Abnormal expression of pan-ras, C-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis. Oncol Rep 2001; 8: 557-561
19. Kersemaekers AM, Fleuren GJ, Kenter GG et al. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 1999; 5: 577-586
20. Aoyama C, Peters J, Senadheera S, Liu P, Shimada H. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction. Diagn Mol Pathol 1998; 7: 324-330 (Pubitemid 29177575)
21. Nair SA, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR. ras and c-myc oncoproteins during tumor progression in the uterine cervix. Tumori 1998; 84: 583-588
22. Zhang A, Maner S, Betz R et al. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 2002; 101: 427-433 (Pubitemid 35050683)
23. Manraj SS, Mustun H, Ghurburrun P, Laniece C, Salamon R. Cancer incidence in Mauritius (1989-1993) (in French). Rev Epidemiol Sante Publique 1997; 45: 257-259
24. Manraj SS, Mustun H, Ghurburrun P, Laniece C, Salamon R. Cancer incidence in Mauritius (1989-1993) (in French). Bull Soc Pathol Exot 1998; 91: 9-12.
25. Karaloglu D, Yazici H, Alatli C et al. Detection of HPV 16 and HPV 18 infection in patients with cervical neoplasia. Eur J Gynaecol Oncol 1996; 17: 296-298 (Pubitemid 26261494)
26. Schneider-Gadicke A, Schwartz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 1986; 5: 2285-2292
27. Karlsen F, Kalantari M, Chitemerere M, Johansson B, Hagmar B. Modification of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest 1994; 4: 604-611 (Pubitemid 24338169)
28. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119: 361-366 (Pubitemid 15051884)
29. Brewer CA, Liao SY, Wilczynski SP et al. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. Gynecol Oncol 1996; 63: 337-344
30. Sepp R, Szabo I, Uda H, Sakamoto H. Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 1994; 47: 318-323 (Pubitemid 24171698)
31. Frank TS, Svoboda-Newman SM, Hsi ED. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for non-isotopic PCR. Diagn Mol Pathol 1996; 5: 220-224
32. de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057.
33. Tieben LM, Schegget J, Minnaar RP et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993; 42: 265. (Pubitemid 23142259)
34. Rolighed J, Bichel P, Lindeberg H. The presence of HPV in cervical biopsies, determined by histology and PCR with 2 different pairs of consensus primers. Eur J Gynaecol Oncol 1997; 18: 365-367 (Pubitemid 27437744)
35. Unger ER, Vernon SD, Lee DR, Miller DL, Reeves WC. Detection of human papillomavirus in archival tissues: comparison of in situ hybridisation and polymerase chain reaction. J Histochem Cytochem 1998; 46: 535-540 (Pubitemid 28158474)
36. Shibata D, Martin WJ, Arnheim N. Analysis of DNA sequences in forty-year-old paraffin-embedded thin tissue sections: a bridge between molecular biology and classical histology. Cancer Res 1988; 48: 4564-4566 (Pubitemid 18198114)
37. Iwamoto KS, Mizuno T, Ito T et al. Feasibility of using decades-old archival tissues in molecular oncology/epidemiology. Am J Pathol 1996; 149: 399-406. (Pubitemid 26256329)
38. Munoz N, Xavier Bosch F, De Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527 (Pubitemid 36159887)
39. Harington J. Epidemiology and aetiology of cancer of the uterine cervix, including the detection of carcinogenic N-nitrosamines in the human vaginal vault. S Afr Med J 1975; 49 (12): 443-445